{"id":"W2943049136","doi":"10.3747/co.26.4595","title":"Real-World Outcomes of Nivolumab and Cabozantinib in Metastatic Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium","year":2019,"lang":"en","type":"article","venue":"Current Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; BC Cancer Foundation; Princess Margaret Cancer Centre; Spinal Cord Injury BC; London Health Sciences Centre; Queen's University; University Health Network; Alberta Cancer Foundation; Sunnybrook Health Science Centre; University of Calgary","funders":"","keywords":"Cabozantinib; Renal cell carcinoma; Medicine; Nivolumab; Oncology; Metastatic Urothelial Carcinoma; Metastatic melanoma; Internal medicine; Metastatic carcinoma; Carcinoma; Cancer research; Urothelial carcinoma; Immunotherapy; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003316268,0.0002517008,0.000765114,0.0009938958,0.0001983031,0.00142804,0.0006189405,0.0004944863,0.0005670992],"category_scores_gemma":[0.01029785,0.0001204741,0.0009399335,0.001957814,0.0002600748,0.000653472,0.0008667376,0.0004798135,0.0001458],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001302628,"about_ca_system_score_gemma":0.0009369276,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00968786,"about_ca_topic_score_gemma":0.01110545,"domain_scores_codex":[0.9963683,0.001257139,0.0005190976,0.000754275,0.0008667571,0.000234523],"domain_scores_gemma":[0.9912708,0.002126724,0.004460244,0.0006815883,0.0009102763,0.000550441],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001985209,0.00009030673,0.9888298,0.0001581167,0.001018744,0.00006702942,0.00007654736,0.0009263716,0.0001872586,0.00007357361,0.00123944,0.005347597],"study_design_scores_gemma":[0.0001784322,0.0003222684,0.9932718,0.00006103766,0.0004637136,0.0003739472,0.0002100777,0.002652635,0.0002881542,0.00005496903,0.002099948,0.00002305665],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9858903,0.001706762,0.0001684801,0.0001865348,0.00001373667,0.00002720011,0.01154535,0.00001053944,0.0004510336],"genre_scores_gemma":[0.9826432,0.0003222288,0.0001776509,0.0000707392,0.00001758852,0.00002833547,0.01667782,0.000005949716,0.00005658882],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00968786,"threshold_uncertainty_score":0.01926297,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08547793021661805,"score_gpt":0.3559964659620393,"score_spread":0.2705185357454213,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}